Cargando…
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Glaucoma is the main cause of irreversible visual loss worldwide, and comprises a group of progressive, age-related, and chronic optic neuropathies. Prostaglandin analogs are considered a first-line treatment in the management of glaucoma and have the best efficacy in reducing intraocular pressure....
Autores principales: | Zhou, Lin, Zhan, Wenyi, Wei, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596770/ https://www.ncbi.nlm.nih.gov/pubmed/36313286 http://dx.doi.org/10.3389/fphar.2022.1015338 |
Ejemplares similares
-
Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
por: Liu, Yuanzhi, et al.
Publicado: (2019) -
Prostaglandin analogues in angle closure glaucoma
por: Gupta, Pulkit, et al.
Publicado: (2011) -
Editorial: Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022
por: Klomp, Sylvia D., et al.
Publicado: (2023) -
Topical Prostaglandin Analogues and Conjunctival Inflammation in Uveitic Glaucoma
por: Taylor, Simon RJ, et al.
Publicado: (2012) -
Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)